Difficulty: Medium
Average Score: 78%
Practice
Aspirin in low doses produces long-lasting inhibition because
Correct answer
B
Rationale
The correct answer is B) Platelets cannot synthesize fresh COX molecules.
Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins involved in inflammation and platelet aggregation. In low doses, aspirin's inhibition of COX in platelets is long-lasting because platelets lack the ability to synthesize new COX enzymes. Once aspirin acetylates and inactivates the existing COX enzymes in platelets, they cannot regenerate these enzymes, leading to a prolonged antiplatelet effect.
Option A) Platelets contain low quantity of COX is incorrect because platelets do contain COX enzymes, albeit in lower quantities compared to other cells.
Option C) Platelets bind aspirin with high affinity is incorrect because aspirin binds irreversibly to COX enzymes, not platelets themselves.
Option D) Platelet COX is inducible is incorrect because platelet COX is not inducible; once inhibited by aspirin, platelets cannot induce the synthesis of new COX enzymes.
Understanding the mechanism of action of aspirin in inhibiting platelet function through COX inhibition is crucial in pharmacology, particularly in the context of cardiovascular diseases where aspirin is commonly used for its antiplatelet effects to reduce the risk of thrombotic events. This knowledge helps healthcare professionals make informed decisions regarding the appropriate use of aspirin therapy in various clinical scenarios.
Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins involved in inflammation and platelet aggregation. In low doses, aspirin's inhibition of COX in platelets is long-lasting because platelets lack the ability to synthesize new COX enzymes. Once aspirin acetylates and inactivates the existing COX enzymes in platelets, they cannot regenerate these enzymes, leading to a prolonged antiplatelet effect.
Option A) Platelets contain low quantity of COX is incorrect because platelets do contain COX enzymes, albeit in lower quantities compared to other cells.
Option C) Platelets bind aspirin with high affinity is incorrect because aspirin binds irreversibly to COX enzymes, not platelets themselves.
Option D) Platelet COX is inducible is incorrect because platelet COX is not inducible; once inhibited by aspirin, platelets cannot induce the synthesis of new COX enzymes.
Understanding the mechanism of action of aspirin in inhibiting platelet function through COX inhibition is crucial in pharmacology, particularly in the context of cardiovascular diseases where aspirin is commonly used for its antiplatelet effects to reduce the risk of thrombotic events. This knowledge helps healthcare professionals make informed decisions regarding the appropriate use of aspirin therapy in various clinical scenarios.